The grace period is over. Twelve predictions on where AI creates value, breaks assumptions and triggers backlash as 2026 ...

Consistent High Ranking Demonstrates Exceptional Value of Forward Enterprise in Delivering Operational Confidence Through ...

If 2024 was the year of proof-of-concept and 2025 was the year of early adoption and scale, 2026 is shaping up to be something different — a year defined by normalization. AI in healthcare won't fade ...

China’s race to build homegrown artificial intelligence chips has collided head on with Nvidia’s H200, the United States ...

Wall Street sees Okta as an AI identity winner for 2026, though rich multiples leave little margin for growth slowdowns.

Oracle (ORCL) is well-positioned to benefit from AI adoption by leveraging its integrated infrastructure, database, and ...

IT leaders will look to make use of agentic systems, focus on projects with productivity gains and rethink workforce ...

Jonathan Ponciano is a financial journalist with nearly a decade of experience covering markets, technology, and entrepreneurship. MoMo Productions / Getty Images At age 65, the average Social ...

AMZN is aggressively investing in AI, custom chips, and open-sourcing its software stack to defend its moat against rivals ...

India is reopening the nuclear playbook. Policy tailwinds, private participation, and a push from 8 GW to 100 GW are creating ...

Discover how the Nordic model blends capitalism and social welfare, compared to the U.S. system, with insights on taxation, social services, and economic efficiency.

The global clinical trials market size was US$ 39,710.5 million in 2021. The global clinical trials market size is forecast to reach US$ 59570.5 million by 2030, growing at a compound annual growth ...